Literature DB >> 25589356

[Fibrohistiocytic tumors of the skin: a heterogeneous group of superficially located mesenchymal neoplasms].

T Mentzel1.   

Abstract

So-called fibrohistiocytic tumors of the skin comprise a heterogeneous spectrum of superficially located neoplasms that often show fibroblastic and/or myofibroblastic differentiation. In this review clinicopathologically important variants of dermatofibroma and dermatofibrosarcoma protuberans and their differential diagnoses are discussed in detail. In addition, the clinicopathological features of atypical fibroxanthoma, angiomatoid fibrous histiocytoma, plexiform fibrohistiocytic tumors and pleomorphic dermal sarcoma are presented. Entities that have to be considered in the differential diagnosis are also mentioned.

Entities:  

Mesh:

Year:  2015        PMID: 25589356     DOI: 10.1007/s00292-014-2032-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  30 in total

1.  Cultural characteristics of malignant histiocytomas and fibrous xanthomas.

Authors:  L OZZELLO; A P STOUT; M R MURRAY
Journal:  Cancer       Date:  1963-03       Impact factor: 6.860

2.  Desmin and CD34 positivity in cellular fibrous histiocytoma: an immunohistochemical analysis of 100 cases.

Authors:  Elgida R Volpicelli; Christopher D M Fletcher
Journal:  J Cutan Pathol       Date:  2012-07-09       Impact factor: 1.587

3.  Plexiform fibrohistiocytic tumor: clinicopathologic analysis of 22 cases.

Authors:  E D Remstein; C A Arndt; A G Nascimento
Journal:  Am J Surg Pathol       Date:  1999-06       Impact factor: 6.394

4.  Malignant dermatofibroma: clinicopathological, immunohistochemical, and molecular analysis of seven cases.

Authors:  Thomas Mentzel; Thomas Wiesner; Lorenzo Cerroni; Markus Hantschke; Heinz Kutzner; Arno Rütten; Michael Häberle; Michele Bisceglia; Frederic Chibon; Jean-Michel Coindre
Journal:  Mod Pathol       Date:  2012-09-21       Impact factor: 7.842

5.  Ultraviolet-induced p53 mutations in atypical fibroxanthoma.

Authors:  A P Dei Tos; R Maestro; C Doglioni; D Gasparotto; M Boiocchi; L Laurino; C D Fletcher
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

6.  An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD.

Authors:  Christopher Moosavi; Prakash Jha; Julie C Fanburg-Smith
Journal:  Ann Diagn Pathol       Date:  2007-10       Impact factor: 2.090

7.  Metastasizing "benign" cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases.

Authors:  Leona A Doyle; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2013-04       Impact factor: 6.394

Review 8.  Cutaneous fibrohistiocytic tumours - an update.

Authors:  Bostjan Luzar; Eduardo Calonje
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

9.  Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.

Authors:  Thomas Mentzel; Leo Schärer; Dmitry V Kazakov; Michal Michal
Journal:  Am J Dermatopathol       Date:  2007-10       Impact factor: 1.533

10.  Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.

Authors:  Julie D R Reimann; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2007-09       Impact factor: 6.394

View more
  3 in total

1.  Dermatofibrosarcoma protuberans of the hallux: A case report with review of the literature.

Authors:  Rafik Elafram; Majdi Ben Romdhane; Nayssem Khessairi; Majdi Sghaier; Hedi Annabi
Journal:  Int J Surg Case Rep       Date:  2022-06-22

2.  Multiple benign fibrous histiocytomas of the mandible: A case report and review of the literature.

Authors:  Yue Wang; Yun Huang; Wei-Xin Cai; Qian Tao
Journal:  Exp Ther Med       Date:  2022-07-27       Impact factor: 2.751

3.  Dermatofibrosarcoma protuberans in a young patient with epidermolysis bullosa: a case report.

Authors:  B Bonaventura; D Kraus; G B Stark; H Fuellgraf; J Kiefer
Journal:  BMC Surg       Date:  2021-02-23       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.